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In voltage-gated cation channels, a recurrent pattern for mutations is the neutralization
of positively charged residues in the voltage-sensing S4 transmembrane segments.These
mutations cause dominant ion channelopathies affecting many tissues such as brain, heart,
and skeletal muscle. Recent studies suggest that the pathogenesis of associated pheno-
types is not limited to alterations in the gating of the ion-conducting alpha pore. Instead,
aberrant so-called omega currents, facilitated by the movement of mutated S4 segments,
alsoappeartocontributetosymptoms.Surprisingly,theseomegacurrentsconductcations
with varying ion selectivity and are activated in either a hyperpolarized or depolarized volt-
age range.This review gives an overview of voltage sensor channelopathies in general and
focuses on pathogenesis of skeletal muscle S4 disorders for which current knowledge is
most advanced.
Keywords: epilepsy and neuromyotonia, long QT syndrome, familial hemiplegic migraine, myotonia and
paramyotonia, hyperkalemic and hypokalemic periodic paralysis, sodium overload, cytotoxic edema, degeneration
INTRODUCTION
Thebasicmotif of thealphasubunitof voltage-gatedcationchan-
nels is a tetrameric association of four domains I–IV, each con-
sisting of six transmembrane helical segments S1–S6, connected
by intracellular and extracellular loops. At the resting potential,
open probability is low. Activation results from a depolarization-
induced conformational change leading to the opening of the
alpha pore. When the pore is pharmacologically blocked, charge
movements in the electrical membrane ﬁeld are measurable as so-
called gating currents. These gating currents are a result of the
outward movement of highly conserved voltage-sensitive S4 seg-
ments which display an arginine or lysine residue at every third
amino acid position, almost vertically aligned (denoted as R1,
R2, R3, etc.). At resting potential, the outermost S4 charge sep-
arates the extracellular ﬂuid from the cytoplasm.With membrane
depolarization, each S4 moves outwardly shifting deeper situated
arginines to the critical position of extra-intracellular separation.
During their outward movement, the S4 segments move in a spi-
ral path through canaliculi of the channel protein made up of
segmentsS1–S3(Figures1and2).Likewise,duringrecoveryfrom
channel inactivation, the S4 segments are thought to move back
to their original position. Because of the narrow constriction sep-
arating extracellular from intracellular compartments, mutations
of the S4 charges may cause either a hyperpolarization-activated
or a depolarization-activated non-speciﬁc cation leak called the
omega current (Figure 2).
An omega current was ﬁrst described in the voltage-gated
potassiumchannelof drosophilaShaker.Inthischannelthemuta-
tion R1H in S4 generates an inward-directed hyperpolarization-
induced proton current that becomes increasingly prominent as
the proton reversal potential EH is shifted to more positive values
(Starace and Bezanilla, 2004). R1 substitutions to residues other
than histidine result in a hyperpolarization-induced inward cur-
rent carried by alkali metal cations rather than protons (Tombola
et al., 2005) indicating that this mutation creates a short-circuit
connection of intracellular and extracellular compartments in
the canaliculus. This current varies with the identity of the
substituted residue: R1S>R1C>R1V∼R1A, has the selectiv-
ity Cs+ >K+ >Li+, and is not affected by alpha pore blockers.
Shaker mutants R2H and R3H conduct protons at potentials cor-
responding to the voltage-dependent movement of S4 charges, as
thecurrentismaximalatpotentialsclosetomidpointof theQON-
voltage relation (Starace et al., 1997; Starace and Bezanilla, 2001).
Further depolarization blocks the omega pore, consistent with
the model that outward S4 movement shifts the short-circuiting
mutant residues out of the canaliculus.
Studies on Shaker potassium channel and domain II of rat
brain sodium channel Nav1.2 suggest that substitution of a single
S4 arginine may be insufﬁcient to produce a non-proton omega
current,but that two adjacent mutations (i.e.,R2/R3 or II-R1/R2)
are required (Sokolov et al., 2005; Gamal El-Din et al., 2010). In
this respect, the presence of alanine at the position equivalent to
R0 in Shaker may therefore enhance the omega current of R1S.
The motif of adjacent arginine replacements recurs in some of the
potassium channel disorders and may be explained by the degree
of accessibility of arginines to the extracellular or intracellular
compartments. However, this does not hold true for all channels
suggesting that position and orientation of the S4 segment and
its environment play an important role as well. Based on current
knowledgeof S4position,inthisreviewR0designateschargeposi-
tionsof S4outsideof thecanaliculusandR1theﬁrstchargeinside
of it.
For human diseases, the channelopathies result from muta-
tions in voltage-gated ion channels. In several of these disorders,
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FIGURE1|S c heme of a voltage-gated ion channel. Bird’s eye view of the
channel consisting of four similar repeats (I to IV).The channel has been cut
open between repeats I and IV to show the opening and closing of the central
pore.The model also shows one of the four voltage sensors S4, which moves
outward when the membrane becomes depolarized and remains in this
position until repolarization.
mutations of speciﬁc charges of S4 segments are known, such
as in epilepsy, hemiplegic migraine, long QT (LQT) syndrome,
paramyotonia congenita, and periodic paralyzes (Table 1). The
underlying mutations generally modify voltage sensitivity of gat-
ing and maximal amplitude of alpha current. Additionally, some
of these mutations have been reported to produce an omega cur-
rent. Most of these are inward currents that result in enhanced
membrane depolarization, contributing to the symptoms of the
channelopathy. Depending on the position of the S4 mutation
and the voltage threshold of activation of the channel, the omega
current can appear in very different voltage ranges.
This review brieﬂy outlines the clinical features and pathogene-
sisof theS4channelopathieswithafocusonmutation-dependent
changesof alphaandomegacurrentsaswellastheircontributions
to the phenotype. It also introduces the concept of membrane bi-
stability in general and in computer simulations incorporating
omega current. Also discussed are the consequences of intra-
cellular sodium overload and tissue degeneration to explain the
non-episodicfeaturesof thechannelopathiesandtheideasbehind
best practice treatment. For further reading, there are reviews
with more emphasis on S4 structure and function (Catterall,
2010),S4mutationsinchannelsof skeletalmuscle(Cannon,2010;
Jurkat-Rott et al., 2010), or drug action in periodic paralyzes and
related channelopathies (Matthews and Hanna, 2010; Tricarico
and Camerino, 2011).
EPILEPSY AND NEUROMYOTONIA
Epilepsy is characterized by recurring episodes of synchronized
electrical discharges of neurons caused by their facilitated depo-
larization within the central nervous system. The symptoms of a
seizuredependonageof thepatient,theunderlyingcause,andthe
brain region involved.
Generalized epilepsy with febrile seizures plus (GEFS+)i s
a childhood-onset syndrome featuring febrile seizures (FS) and
afebrile epileptic convulsions within the same pedigree. The pen-
etrance is ∼60%. In two-thirds of affected individuals either FS
persistafterthesixthyearoflifeorafebrilegeneralizedtonic-clonic
seizuresadditionallyoccur(FS+).GEFS+typeIIiscausedamong
othersbymissensemutationsinthealphasubunitof theneuronal
sodiumchannelNav1.1,encodedbySCN1A.Mutationsfrequently
destabilize the fast-inactivated state, resulting in a persistent
inward sodium current that depolarizes the membrane potential
to a value closer to the Nav1.1 threshold (facilitated spike gen-
eration). Additionally, a few mutations result in loss-of-function
by trafﬁcking defects (Catterall et al., 2010; Escayg and Goldin,
2010). S4 mutations II-R1C, IV-R4H, and IV-R7C (Figure 3)
result in additional loss-of-function effects such as decreased cur-
rent amplitude and stabilization of the inactivated state (Alekov
et al., 2000; Spampanato et al., 2001; Lossin et al., 2003; Barela
et al., 2006; Vanoye et al., 2006). Apparently, loss-of-function in
inhibitory neurons produces overexcitability (Martin et al.,2010)
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FIGURE 2 | Omega pores and currents dependent on the R position.
(A) Replacement of the outermost arginine (red) by a neutral amino acid (gray)
such as glycine (R1G) opens a conductive pathway through the polarized
membrane, resulting in an omega current (red). At depolarized potentials at
which the S4 segment moves outward, the conductive pathway is closed by a
deeper arginine and the omega current ceases. In contrast the replacement
of a deeper arginine (R3G) only opens the omega pore if the membrane is
depolarized. (B) Homology model of domain I in hNav1.4 based on crystal
structure of NaVAb (activated-closed; crystal structure at 0mV), using
Modeller. Positions of arginine and lysine residues of DIS4 are shown, relative
to the putative gating pore constriction (arrow). Modiﬁed from Groome and
Winston (2012). (C) Comparison of current-voltage (I/V) traces for wild type
hNav1.4 and R222G, with plots of raw I/V, linear leak, and normalized current
(linear leak subtracted from IV and normalized to gating current at +40mV).
The mutation R222G causes HypoPP type 2. External solution contained
120 mM K
+ and 1μMTTX. Modiﬁed from Holzherr et al. (2010).
similar to gain-of-function effects in excitatory neurons (Kahlig
et al.,2006,2010).
Severe myoclonic epilepsy of infancy (SMEI), or Dravet syn-
drome, is characterized by clonic or tonic-clonic seizures that
occur in the ﬁrst year of life,are often prolonged,and are typically
associated with fever. During the course of the disease, patients
develop additional afebrile generalized and partial seizures. Cog-
nitive deterioration appears in early childhood. In contrast to
GEFS+, the syndrome is resistant to pharmacotherapy, although
stiripentolseemstohaveapositiveeffectbyenhancingGABAergic
neurotransmission. Cranial magnetic resonance (MR) imaging
in patients reveals focal and generalized atrophy. Because some
patients with SMEI have a family history of febrile or afebrile
seizures, and in some families GEFS+ and SMEI overlap, SMEI
may therefore be regarded as the most severe phenotype of the
GEFS+ spectrum (Mullen and Scheffer, 2009). SMEI is caused
by mutations in SCN1A encoding Nav1.1. Most SMEI mutations
cause loss-of-function due to nonsense mutations demonstrat-
ing that haploinsufﬁciency of SCN1A is pathogenic (Oakley et al.,
2011). The loss-of-function of Nav1.1 channels results in reduced
action potential (AP) ﬁring in hippocampal inhibitory neurons,
thus generating overexcitability. IV-R4C causes gain-of-function
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bydestabilizingfastinactivationandproducingpersistentcurrents
(Rhodes et al.,2004) that may be inhibited by the sodium channel
blocker ranolazine (Kahlig et al.,2010; Figure 3).
Benignfamilialneonatalseizures(BFNS)aredominantlyinher-
ited with a penetrance of 85%. The seizures manifest within the
ﬁrstweeksoflifeandtypicallydisappearspontaneouslyafterweeks
to months. Seizures may have a partial onset or may appear as
generalized. Accordingly, ictal EEGs show focal and generalized
discharges.InterictalEEGsaremostlynormal.Theriskof seizures
recurringinadulthoodis∼15%,butpsychomotordevelopmentis
usuallynormal.CausativemutationshavebeenidentiﬁedinKv7.2
and Kv7.3 potassium channels encoded by KCNQ2 and KCNQ3
respectively that interact with each other and constitute the so-
called M-current, an important regulator of membrane potential
neartheAPthreshold.Co-expressionofheteromericwildtypeand
mutant Kv7.2/Kv7.3 channels usually reveals a potassium current
reduction of ∼20–30% in the setting of haploinsufﬁciency. This
causesBFNSbydepolarizingthemembraneandfacilitatingAPﬁr-
ing (Maljevic et al.,2008). In contrast,S4 mutations of the pattern
R3W/Q (Figure 3) produce a dominant negative effect on co-
expressed wild type brought about by a drastic depolarizing shift
of the activation curve and slowing of the activation time course
(Dedek et al., 2001; Wuttke et al., 2007; Miceli et al., 2012). This
suppression of inhibitory neurons explains the hyperexcitability
that affects central as well as peripheral neurons. The latter locus
ofhyperexcitabilityleadstoadditionalneuromyotoniaalsotermed
peripheralnervehyperexcitability(PNH).Thisdisorderischarac-
terized by short spells of spontaneous skeletal muscle overactivity
resulting in twitching, undulation, or rippling of the muscles and
painfulcramps,sothatthephenotypefortheseS4mutationcarri-
ers is BFNS-PNH. Omega currents have been implicated in BFNS
for the analogous Kv7.4 channel. There, corresponding R3W/Q
mutations generate non-speciﬁc depolarization-induced cation
outward currents of ∼1% of the pore current amplitude, at the
+40mV voltage step (Miceli et al., 2012). In Kv7 channels, single
mutations of R1 and R3 fulﬁll the concept of adjacent arginine
replacements because there is a glutamine at position R2.
LONG QT SYNDROME
Long QT syndrome is named for an elongated QT interval in
the electrocardiogram. It is caused by lengthening of the repolar-
ization phase of the cardiac ventricular AP. Because duration of
the cardiac AP is dispersed in different regions of the ventricle
depending on regional channel expression, any disproportionate
FIGURE3|S 4sequences of channels with an R0 to R6 mutation.
Positively charged residues in R0 to R6 positions are delineated with a
shaded background (gray).The constriction of the omega pore lies
between R2 and R3.Therefore an inward movement of S4 due to
hyperpolarization opens the omega pore if R1 or R2 is replaced by a
neutral amino acid. An outward movement of S4 due to depolarization
opens the omega pore if R3 or R4 is replaced by a neutral amino acid.
These gray-background arginines are boxed.The Shaker K
+ channel serves
as reference. Neutral replacements of its arginines R2 and R3 have been
described as proton transporters.
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prolongationof theAPincreasestheprobabilityforre-entryof the
depolarizationwave,earlyafter-depolarizationsandthus,arrhyth-
mia. Associated ECG ﬁndings may be ventricular bigemini and
torsadedepointes inwhichtheQRScomplextwistsaroundtheiso-
electricaxisintheelectrocardiogram.Bythis,syncopeandsudden
deathmayresultinyoungandotherwisehealthyindividuals.LQT
syndrome (LQTS) is caused among others by loss-of-function of
potassium channels Kv7.1 encoded by KCNQ1 or Kv11.1 encoded
by KCNH2 andbygain-of-functionof theNav1.5sodiumchannel
encoded by SCN5A.
Kv7.1 currents deactivate very slowly allowing adaptive short-
ening of the AP during tachycardia by incomplete deactivation.
Therefore, loss-of-function in Kv7.1 leads to arrhythmia espe-
cially at elevated heart rate due to physical or emotional stress.
R1C decreases current amplitude which explains the LQT in the
electrocardiogram, but also produces a hyperpolarizing shift of
the voltage dependence of activation and tail currents, thereby
explaining the additional atrial ﬁbrillation in these patients (Bar-
tos et al., 2011). R5H/C produce a slowed rate of activation, a
positive voltage shift of activation and/or dominant suppression
of co-expressed wild type (Franqueza et al., 1999; Mohammad-
Panah et al., 1999; Chouabe et al., 2000). R1, R3, and R5 mutants
all fulﬁll the concept of adjacent arginine replacements because
there is a glutamine at R2 and a histidine at R4 (Figure 3).
Kv11.1activatesanddeactivatesrelativelyslowlyincomparison
to a rapid inactivation. LQT mutations suppress repolarization of
the myocardial AP and lengthen the QT interval by either loss-of-
functionorhaploinsufﬁciency.Adominantnegativeeffectmaybe
achieved by current reduction of the tetrameric channel complex.
FortheLQTdoublemutationof R0/R1,thereisnofunctionaldata
buttheretwoadjacentargininesarechanged(Figure3).Thepoint
mutation R3C reduces current amplitude and accelerates deacti-
vation thereby slowing repolarization of the cardiacAP in its ﬁnal
phase (Nakajima et al.,1999).
Nav1.5 initiates the cardiac AP. LQT mutants frequently con-
ductapersistentinwardcurrentduringmembranedepolarization
and single channel recordings show ﬂuctuation between normal
andnon-inactivatinggatingmodes.I-R3Q/Wshiftthesteady-state
inactivation curve to the right (Bezzina et al., 2003). IV-R0L/Q
delay inactivation (Makita et al., 1998), IV-R1P impairs inactiva-
tion or shifts the steady-state inactivation curve to the left (Ruan
et al., 2007) and decreases inactivation upon stretch modula-
tion (Banderali et al.,2010). Mutations IV-R7C/H show dispersed
re-openings(Dumaineetal.,1996;Figure3).Ithasyettobeestab-
lished that omega currents play a role in the pathogenesis of Kv or
Nav LQTS channelopathies, but the ﬁnding of mutations in these
cardiac disorders in R1–R3 residues of S4 raises that possibility
(Table 1; Sokolov et al.,2007).
HEMIPLEGIC MIGRAINE
Familial hemiplegic migraine (FHM) presents with characteristic
unilateral migraine headaches accompanied by nausea, phono-,
and photophobia. Episodes are typically precipitated by an aura
withsymptomsof bothhyper-andhypo-excitabilitysuchasapha-
sia, dysarthria, vertigo, homonymous hemianopsia, cheiro-oral
paresthesias, and some degree of (primarily) unilateral paresis.
Additionally, ataxia and cerebellar degeneration are frequently
part of the FHM phenotype. Up to 50% of cases are caused
by mutations in Cav2.1 encoded by CACNA1A. Current patho-
genesis models of migraine with aura suggests cortical spreading
depressionwhichconsistsofaninitialbriefspikeofincreasedneu-
ronal activity followed by long-lasting suppression of excitability
spreading across the cortex at 1–3mm/min. The depression wave
is associated with long-lasting depolarization associated with ele-
vation of extracellular potassium and intracellular sodium. The
progress of FHM correlates to the succession of symptoms during
the aura initiating the migraine attacks. FHM1 includes sporadic
hemiplegic migraine with progressive cerebellar ataxia. The aura
may be prolonged and confusion and loss of consciousness may
occur. In the interval, some families additionally present with
epilepsy,retinal degeneration,hypacusis,and persistent cerebellar
dysfunction with Purkinje cell atrophy. While migraine is mainly
caused by gain-of-function, loss-of-function may lead to addi-
tional ataxia. Of the seven known S4 mutations in Cav2.1, there
is functional data for only two. I-R0Q increases open probabil-
ity and channel density in vitro (Kraus et al., 1998; Hans et al.,
1999). In a knock-in mouse this mutation generates increased
current density in cerebellar neurons, enhanced transmission at
theneuromuscularjunction,andreducedthresholdandincreased
velocity of cortical spreading depression, effects that are compat-
ible with an omega current (van den Maagdenberg et al., 2004;
Figure 3). II-R1Q shifts activation to the left but decreases peak
current (Kraus et al., 2000). Omega currents produced by either
of these mutations have yet to be demonstrated.
SODIUM CHANNEL MYOTONIA AND PARAMYOTONIA
Myotonia is an involuntary slowed relaxation after a forceful vol-
untary muscle contraction, experienced by the patient as muscle
stiffness. After making a forceful ﬁst or eyelid closure, the patient
cannot reopen their hand or eye. Repetition decreases the myoto-
nia,aphenomenoncalledwarm-up.Electricalhyperexcitabilityof
the muscle ﬁber membrane is the basis for myotonia, apparent in
the form of repetitive APs in the EMG. Needle insertions into the
resting muscle elicit myotonic bursts,i.e.,runs of APs with ampli-
tude and frequency modulation that sound like dive bombers.
Autosomal dominantly inherited myotonia can be caused among
others by mutations in SCN4A, the gene encoding the alpha
subunit of the voltage-gated sodium channel of skeletal muscle,
Nav1.4 (Heine et al., 1993), essential for generation of the muscle
ﬁber AP. Most mutations destabilize the fast-inactivated state so
thatthechannelinactivatesslowerandincompletely(Lercheetal.,
1993). The resulting subthreshold membrane potential facilitates
APgeneration.I-R3Wcausestypicalmyotoniawithwarm-upphe-
nomenon and transient weakness (Lee et al., 2009). However, no
functional data are available.
Paramyotonia (PC) is also caused by dominant SCN4A mis-
sense mutations. The cardinal symptom is cold-induced muscle
stiffness that increases with continued activity called paradoxical
myotonia, or paramyotonia for short. In most families, on inten-
sive cooling the stiffness gives way to ﬂaccid weakness or even
to paralysis which is caused by severe membrane depolarization
(Lehmann-Horn et al., 1987; Lerche et al., 1996). Families with
IV-R0H/C/S/L/P also have episodes of generalized periodic paral-
ysis (Lehmann-Horn and Jurkat-Rott, 1999). Such attacks occur
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spontaneously and can be triggered by rest or elevated serum
potassium. They are of much shorter duration than the cold-
induced weakness that usually lasts for several hours even after
the muscles are re-warmed. During cooling, PC muscle ﬁbers
slowlydepolarizetoanextentgreaterthanthatobservedinnormal
muscle ﬁbers. The depolarization is associated with long-lasting
bursts of APs which cease when the membrane potential reaches
−55mV. At this potential sodium channels inactivate so that
muscle becomes inexcitable and paralyzed. Causative mutations
generally slow the entry into, and accelerate recovery from, fast
inactivation (Yang et al., 1994). IV-R0 mutations slow deactiva-
tion, in addition to destabilizing the fast-inactivated state (Fan
et al., 1996; Lerche et al., 1996; Featherstone et al., 1998; Groome
et al., 1999; Mitrovic et al., 1999). No omega current is observed
(Francis et al.,2011),possibly because R0 is located outside of the
canaliculus (Figures 2 and 3).
PERIODIC PARALYSIS
Autosomaldominanthypokalemicperiodicparalysis(HypoPP)is
characterized by episodes of ﬂaccid generalized muscle weakness
accompaniedbylowserumpotassiumlevels.Triggersfortheweak-
ness are carbohydrates and insulin with subsequent hypokalemia,
rest after exercise, and cooling. Oral potassium administration
accelerates the recovery of muscle strength. Native patient mus-
cle ﬁbers show long-lasting membrane depolarization paradoxi-
cally triggered by lowering of extracellular potassium,resulting in
an inactivation of sodium channels necessary for AP generation
(Jurkat-Rott et al., 2000). This effect is exacerbated in the pres-
ence of insulin (Bond and Gordon, 1993; Ruff, 1999). Permanent
progressive weakness is additionally found in ∼60% of patients
whereby muscle degenerates and is increasingly replaced by fatty
tissue. The causative mutations are located in the skeletal muscle
calcium channel Cav1.1 encoded by CACNA1S (HypoPP-1) and
the skeletal muscle sodium channel Nav1.4 encoded by SCN4A.
Given the ﬁnding that all but one of these mutations neutralize
a positively charged S4 residue, it is not surprising that a role for
omega currents as a causal factor in the pathogenesis of the chan-
nelopathies has been most clearly demonstrated for the periodic
paralyzes.
Functional studies of the alpha currents of either of these
channels do not satisfactorily explain the phenotype. In Cav1.1,
II-R1H/G and IV-R2H/G (Figure 3) lead to loss-of-function in
the sense of current amplitude reduction, slowing of activation,
reduced open probability, left shift of steady-state inactivation,
reduced amplitude and broadening of APs (Lehmann-Horn et al.,
1995;Lapieetal.,1996;Jurkat-Rottetal.,1998;Morrilletal.,1998;
MorrillandCannon,1999;Kuzmenkinetal.,2007).Noneof these
gating defects are expected to lead to increased depolarization.
Similarly, in Nav1.4, II-R1H, II-R2H/G/S/C, and II-R3G/W/Q
showreducedcurrentamplitude,leftshiftof steady-statefastinac-
tivation,enhancedfastandslowinactivation,slowedrecoveryafter
long depolarizations, and reduced AP amplitudes (Bulman et al.,
1999;Jurkat-Rottetal.,2000;Struyketal.,2000;Bendahhouetal.,
2001; Kuzmenkin et al., 2002; Carle et al., 2006; Wu et al., 2008,
2011).Thesedefectswouldnotcontributetodepolarizationeither.
In Nav1.4,II-R1H,II-R2H/G/C/S,andIII-R2Qmutationsgen-
erate omega currents that are activated by hyperpolarization,
are still active at the usual resting potential, but are closed
by depolarizations large enough to activate and thus, move S4
(Figure 3). Their amplitude is about 1% of the alpha pore cur-
rent. Substitution of these arginines by the bulky histidine residue
enables proton transport only; other cations do not seem to have
enough space to pass (Sokolov et al., 2007; Struyk and Can-
non, 2007; Francis et al., 2011). Substitution of these arginines
with uncharged resides such as glycine allow an inwardly recti-
fying ﬂow of small monovalent cations whereby potassium and
cesium are preferred over sodium or lithium (Sokolov et al.,2007;
Struyk et al., 2008). Figure 2C shows current-voltage relation-
ships for R222G/hNaV1.4 channels from experiments performed
in our lab as an example (Holzherr et al., 2010). Omega pores
conduct currents that show an above-linear increase in ampli-
tude with hyper- or depolarization although the electrical ﬁeld is
focused to a single amino acid (Ohm resistor) and not constantly
increasingwithinthemembrane(constantﬁeldtheory).Thenon-
linearity of the omega current reﬂects the stochastic process of
a voltage-dependent open probability and follows a Boltzmann
distribution.
Guanidinium, a derivative of arginine, has greater than 10
times the conductance through the omega pore than monova-
lent cations, while divalent and trivalent cations block the omega
pore at mM concentrations (Sokolov et al., 2010). In that study, a
screen of guanidine derivatives as potential blockers of the path-
ogenic omega current in HypoPP yielded one compound, 1-(2-4
xylyl) guanine that exhibited similar potency for block compared
tothedivalentcationstested.Inaddition,thereisaninwardcation
leak current at hyperpolarized potentials in native muscle of R1H
knock-in mice with omega features (Wu et al.,2011). The conclu-
sion from these alternative approaches to study omega currents is
that they contribute to the depolarization leading to inexcitability
andweakness.Nevertheless,despitesimilaritiesofsodiumchannel
omegacurrentswiththoseinShaker producedbyR1Hmutations,
their blockade is quite different, suggesting differences in shape,
size, and exact cation pathway along the canaliculi of these chan-
nels. Perhaps this phenomenon is related to the postulation that
twoadjacentmutatedchargespromoteomegacurrentsinvoltage-
gated potassium channels, a requisite that does not hold true for
sodium channels.
In contrast to the hyperpolarization-induced omega currents
from substitutions of II-R1 and II-R2, II-R3G/Q/W mutations
generate Nav1.4 cation currents that are activated by depolariza-
tion(Figure3).Thismeansthattheomegacurrentsareconducted
whenS4isintheactivatedorinactivatedstate,butnotintheresting
state. This omega current is deactivated at hyperpolarized mem-
brane potentials (Sokolov et al., 2008). The associated phenotype
differsslightlyintheictalserumpotassiumlevelswhichcanbelow
ornormal(normokalemicperiodicparalysis,NormoPP).Also,the
reaction to oral potassium administration may be different than
for HypoPP – anything from amelioration to worsening of the
weakness.
For II-R1H/Q and IV-R2H/G Cav1.1 channel mutations
(Figure 3), no direct omega currents have been shown. However,
in native patient muscle there is an inward cation leak current at
hyperpolarized potentials with omega features (Jurkat-Rott et al.,
2009). Also, based on these measurements, the periodic paralysis
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episodes can be successfully modeled. The underlying idea is that
depolarized muscle ﬁbers will be paralyzed, and that polarized
ﬁbers will be fully functional. If transitions between these two
situations are reversible, the membrane potential is bi-stable.
BI-STABILITY OF MEMBRANE POTENTIAL
P-states are the electrically stable resting membrane potentials of
a cell in the nomenclature of Jurkat-Rott et al. (2009). Normal
cells reveal a bimodal distribution around the stable membrane
potentials P1 and P2. At physiological conditions, most ﬁbers are
highly negative polarized and in the excitable P1-state which fol-
lows the predictions of the Goldman–Hodgkin–Katz equation.
Upon an increased sodium conductance,e.g.,by omega pores,the
fraction of cells in the (depolarized) P2-state is increased. With
slow depolarization,voltage-gated sodium channels might inacti-
vate via closed-state inactivation and render the cells inexcitable.
Incontrast,cellsthatremainintheP1-stateareonlyslightlydepo-
larized and thus still excitable. This bi-stability is the result of
inwardly rectifying potassium channels (Kir), which open with
hyperpolarization and close with depolarization (Figure4A). The
bi-stability is the reason that only a small increase in sodium con-
ductance, e.g., by an omega pore, is required to shift cells from
the P1- to the P2-state (Figure4B).Vice versa,a repolarizing con-
ductance can shift the membrane back to the P1-state (Figure 4).
Transitions between the P1- and P2-states can occur when any
trigger drives the system closer to a limit point or shifts a limit
point. If the limit points of both states (LP1 and LP2) are situated
at different K+ values, the system shows hysteresis (Figure 4C). If
external K+ is considered as a control parameter, it is shown to
play an important role in driving the system to its limits, and set
the stage during“physiological”hypokalemia, for the paradoxical
depolarization triggered by a slight increase in sodium conduc-
tance provided by an omega current. A signiﬁcant role for the
activated omega pore as a causal factor in the pathogenesis of
HypoPP is supported by the computer model whose details are
given in theAppendix and whose parameters are given in Table 2.
A drop of serum K+ will decrease Kir conductance. Although
the Nernst equation predicts hyperpolarization when external K+
is reduced, the hypokalemia-induced reduction of Kir conduc-
tance may shift the cells from the P1- to the P2-state (Figure 4C).
Therefore,cells show a bimodal distribution of membrane poten-
tials especially at low K+. This phenomenon is called paradoxical
depolarization(Jurkat-RottandLehmann-Horn,2007;Struykand
Cannon,2008;Jurkat-Rottetal.,2009).Notsurprisingly,decreased
conductance in mutant Kir channels contributes to the pathogen-
esis of episodic paralysis associated with thyrotoxicosis (Kir 2.6;
Ryan et al., 2010; Cheng et al., 2011), periodic paralysis and car-
diac arrhythmia in Tawil–Anderson’s syndrome (Kir 2.1; Plaster
FIGURE4|E f f ects of omega currents schematically (A) and in a
computer simulation (B). (A)The current-voltage relationship of K ir
potassium channels shows a voltage range characterized by a “negative”
resistance.This negativity leads to membrane bi-stability. Whereas small
instantaneous changes of P1 will be compensated for (P1 is therefore a
stable membrane potential), larger depolarizing artifacts will cause a jump of
P1 to the limit point LP2. P1 can be regained by substantial repolarizing
inﬂuences like the Na/K pump. (B)The curve is downwardly shifted by an
omega Na
+ current. Limit point LP1 is a very instable membrane potential
that will be shifted to P2 by even smallest instantaneous changes. In the
P2-state the cell membrane will be electrically stable. (C) Membrane
potentials P for various [K
+]o values and for various omega pore
conductances (in μS/cm
2). Reducing [K
+]o ﬁrst leads to hyperpolarization until
the limit point (LP1) is reached at which the membrane potential becomes
instable and jumps to the depolarized state of about −58mV. From there,
increasing [K
+]o takes the potential along the curve until LP2 is reached. LP2
is the starting point for the repolarization.The curves of LP1 and LP2 meet in
the cusp point, CP .The region inside the cusp (bounded by LP1, LP2, and CP)
is bi-stable. In contrast omega pore conductances larger than 18μS/cm
2
result in gradual depolarization without bi-stability.The model reveals that an
omega pore shifts LP1 and LP2 (the cusp) to the right, i.e., less severe
hypokalemia is required to shift cells from the P1- to the P2-state.The
membrane potentials yielded by the computer simulation were compared
with values measured for muscle ﬁbers by use of microelectrodes: open
symbols stand for human controls (−83±5mV in 95% of ﬁbers at 4mM K
+,
−99±3mV for 87% at 1.5mM K
+, and −58mV for 91% at 1mM K
+); ﬁlled
symbols for HypoPP patients with either Cav1.1-R1239H (circle: −74 ±5mV
in 76% of ﬁbers at 4mM K
+)o rC a v1.1-R528H (triangle: −75±5m Vi n9 1 %
of ﬁbers at 4mM K
+); at 1.5mM K
+, 95% of the patients’ ﬁbers −56mV
(square; n=127). Modiﬁed after Jurkat-Rott et al. (2010).
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T a b l e2|P a r ameters of the catastrophe model.
Parameter Value Unit
GATING PARAMETERS OF NaV,K V,AND CLC
ˆ Eomega −110 mV
Aomega 34 mV
ˆ gNaV 268 mS/cm2
ˆ gNaL 2.75 μS/cm2
ˆ gKV 21.6 mS/cm2
ˆ gClC 0.5 mS/cm2
ˆ gir 0.0485 mS/cm2
KS 0.0475 mM2
KK 5m M 2
δ 0.2 –
ˆ Jp 8 Nmolcm−2 s−1
KmK 1m M
KmNa 8m M
LH 1.25×10−10 lcm −2 N−1 s−1
EXTRAAND INITIAL INTRACELLULAR CONCENTRATIONS
ˆ cNa+
e + ˆ cK+
e 141.5 mM
ˆ cCl−
e 108 mM
ˆ cFix−
e 25.8 mM
ˆ cNeutral
e 10 mM
ˆ cNa+
i 15.6 mM
ˆ cK+
i 132.3 mM
ˆ cS
i 8.9 mM
ˆ cCl−
i 4.3 mM
ˆ cFix−
i 124.1 mM
EH+ −18.5 mV
V i 3.38 μl
¯ cH2O 55555 mM
PARAMETERS FOR IONANDWATER FLUXES
ˆ αm 0.288 ms−1
ˆ βm 1.38 ms−1
ˆ Em −42 mV
Kαm 10 mV
Kβm 18 mV
ˆ αh 0.0081 ms−1
ˆ βh 4.38 ms−1
ˆ Eh −45 mV
Kαh 14.7 mV
Kβh 9m V
ˆ ES −85 mV
AS 6m V
ˆ αn 0.0131 ms−1
ˆ βn 0.067 ms−1
ˆ En −37 mV
Kαn 7m V
Kβn 40 mV
ˆ EhK −30 mV
KτhK 25.75 mV
AhK 7. 5 m V
ˆ Ea 70 mV
Aa 150 mV
(Continued)
Parameter Value Unit
PHYSICALAND STRUCTURAL PARAMETERS
Df 70 μm
η 2–
¯ cm 1 μF/cm2
zFix −1.3 –
R 8.3145 Jmol−1 K−1
T 311.15 K
F 96485 C/mol
etal.,2001)andunderliesbarium-inducedaugmentationof para-
doxical depolarization of skeletal muscle ﬁbers in low external K+
(Kir 2.1;StruykandCannon,2008).Decreasedconductanceof the
ATP-sensitive K channel in skeletal muscle may also be a causative
factorinhypokalemic-induceddepolarization,atleastinresponse
to insulin (Tricarico et al.,1998). It has been proposed that part of
the therapeutic effect of acetazolamide in HypoPP is its action to
promotetheactivationof severaldifferenttypesof skeletalmuscle
potassium channels, which may offset the decreased conductance
of Kir (for review see Matthews and Hanna, 2010).
If the omega pore conductance is >18μS/cm2 (for the condi-
tions in Figure 4C), the bi-stability is replaced by a single stable
resting potential. The value depends on the conductance ratio
gK/gω with gK carried by additional (e.g., delayed rectifying) Kv
channels which are less dependent on extracellular K+ than are
Kir channels. In this monostable system, the membrane potential
can vary between −74 and −58mV (Figure 4C).
Usually the majority of normal cells do not become inexcitable
in response to decreased serum K+, because the limit points are
located at very low K+ that do not occur physiologically. However
in the presence of an omega current,the limit points are shifted to
higher K+, and transitions between the states are possible under
physiological conditions. HypoPP seems to be caused by such a
shift. For instance, computer simulation of the effect of R669H
onVrest in response to low external K+ predicts a decrease in the
threshold for paradoxical depolarization of muscle ﬁbers, similar
to that observed experimentally with barium poisoning (Struyk
and Cannon, 2008). Cation ionophores like amphotericin B and
gramicidin can mimic the omega pore current and serve as a suc-
cessful, pharmacological in vitro model for HypoPP (Jurkat-Rott
et al., 2009). Based on the ionophore experiments, the fraction of
ﬁbers in the P2-state may correspond to the chronic weakness in
HypoPPpatients.Typicaltriggerssuchasglucoseandinsulincaus-
ing hypokalemia will further increase this fraction and precipitate
a paralytic attack. The pharmacological computer model predicts
that smaller omega currents require a more severe hypokalemia
of the patients to shift cells into the P2-state than larger omega
currents.
SODIUM OVERLOAD, CYTOTOXIC EDEMA, AND TISSUE
DEGENERATION
Bytacklingthequestionastowhethersodiuminﬂux(e.g.,through
omega pores) increases the cytoplasmic sodium concentration, a
23Na MR sequence was developed (Nielles-Vallespin et al., 2007)
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies June 2012 | Volume 3 | Article 112 | 10Jurkat-Rott et al. Omega pores in channelopathies
FIGURE 5 |
1H and
23Na measurements in the calf muscles of
HypoPP patients. (A–F)T2-weighted STIR
1H (left) and
23Na-MR
images (right) from a healthy control (A,B) and the propositus of a
HypoPP family, a 37-year-old female harboring the Cav1.1-R1239H
mutation (C–F).The images in (C,D) were taken before treatment and
the images in (E,F) were taken after treatment with 250mg/d
acetazolamide for 4weeks. Note the very high proton intensities in
STIR (C) and the elevated Na
+ concentration before treatment (D),
arrows pointing at highest Na signal intensities) and their improvement
after treatment.The central reference contains 0.3% NaCl solution;
occasional side tubes containing 0.3% NaCl in 1% agarose (left) and
0.6% NaCl in H2O (right) were additional standards. (G–I) Axial
T1-weighted MR images from family members patients: the female’s
80-year-old grandmother whose limb muscles were almost completely
replaced with fat (G), the female’s 35-year-old sister (I), and the
55-year-old uncle (H,G). Modiﬁed after Jurkat-Rott et al. (2009).
thatindeedrevealedamusclesodiumoverloadinHypoPPpatients
(Figure 5). In addition, 1H-MR images (MRI) with a short-tau
inversion recovery (STIR) sequence displayed an edema in the
muscles of these HypoPP patients (Figures 5A–F). Therefore the
question arose as to whether the edema was caused by a cyto-
plasmic sodium accumulation and osmotic imbalance, or by an
interstitial edema, e.g., by an inﬂammation. To answer this ques-
tion the MRI technique was further improved to a 23Na MRI
inversion recovery sequence (Na-IR) which partially suppresses
the signal raised by free sodium in the extracellular ﬂuid and
thus mainly represents cytoplasmic sodium (Nagel et al., 2011).
In the HypoPP patients the nature of the edema was cytoplasmic.
It seemed to be cytotoxic as all patients who showed the edema
presented with a chronic weakness and muscle degeneration with
age (Figures 5G–I).
In parallel with the concept of degeneration caused by sodium
overload, ictal cytotoxic edema during the long-lasting depolar-
ization (spreading depression) has been frequently reported in
FHM (for example Chabriat et al., 2000; Butteriss et al., 2003)
and has been suggested to sustain the long-lasting aura (Iizuka
et al., 2006) and contribute to neurodegeneration (Carreño et al.,
2011). Likewise, ictal edema is associated with neuronal degener-
ation and sclerosis of the hippocampus in FSs (Scott et al., 2003,
2006; Sokol et al.,2003). Therefore,it is possible that intracellular
sodium overload may contribute to neuronal as well as muscle
channelopathies.
REPOLARIZATION AND RELIEF OF THE CYTOTOXIC EDEMA
Guided by the experience that acetazolamide has favorable effects
on the episodic weakness in the periodic paralyzes (Resnick
et al., 1968), this agent was administered to HypoPP patients and
reducedthechronicweaknessof thepatientsaswellasthesodium
overload and edema in the MRI (Figure 5). In the pharmacologi-
cal in vitro model of HypoPP using an ionophore, acetazolamide
shifted many ﬁbers from the P2- to the P1-state. This in vitro
effect was considered to be responsible for the positive, in vivo
effects (Jurkat-Rott et al., 2009). Thus, drugs that repolarize the
ﬁber membrane may prevent progression of the cell degeneration
by reducing the cytotoxic edema. Supporting the idea that FHM
and epilepsy share similar pathomechanisms to HypoPP, it is not
surprising that acetazolamide is standard treatment option for
both epilepsy (Wolf, 2011) and FHM (Russell and Ducros,2011).
www.frontiersin.org June 2012 | Volume 3 | Article 112 | 11Jurkat-Rott et al. Omega pores in channelopathies
ACKNOWLEDGMENTS
The work was supported by research grants from the Else Kröner-
Fresenius-Stiftung and the BMBF (IonoNeurOnet),both to Karin
Jurkat-Rott and Frank Lehmann-Horn (2010_A27), and by NIH
1R15NS064556-01 to James Groome. Frank Lehmann-Horn is
endowed Senior Research Professor of the non-proﬁt Hertie-
Foundation. We thank M. Fauler and V. Winston (ISU) for their
contributions to the computer models.
REFERENCES
Alekov, A., Rahman, M. M., Mitrovic,
N., Lehmann-Horn, F., and Lerche,
H. (2000). A sodium channel muta-
tioncausingepilepsyinmanexhibits
subtledefectsinfastinactivationand
activationinvitro.J.Physiol.(Lond.)
529, 533–539.
Alonso, I., Barros, J., Tuna, A., Seixas,
A., Coutinho, P., Sequeiros, J., and
Silveira, I. (2004). A novel R1347Q
mutation in the predicted voltage
sensor segment of the P/Q-type
calcium-channel alpha-subunit in
a family with progressive cerebel-
lar ataxia and hemiplegic migraine.
Clin. Genet. 65, 70–72.
Banderali, U., Juranka, P. F., Clark, R.
B., Giles, W. R., and Morris, C.
E. (2010). Impaired stretch modu-
lation in potentially lethal cardiac
sodium channel mutants. Channels
(Austin) 4, 12–21.
Barela, A. J., Waddy, S. P., Lickfett, J.
G., Hunter, J., Anido, A., Helmers,
S. L., Goldin, A. L., and Escayg,
A. (2006). An epilepsy mutation
in the sodium channel SCN1A
that decreases channel excitability. J.
Neurosci. 26, 2714–2723.
Bartos, D. C., Duchatelet, S., Burgess,
D. E., Klug, D., Denjoy, I., Peat,
R., Lupoglazoff, J. M., Fressart, V.,
Berthet, M., Ackerman, M. J., Janu-
ary, C. T., Guicheney, P., and Delisle,
B. P. (2011). R231C mutation in
KCNQ1 causes long QT syndrome
type 1 and familial atrial ﬁbrillation.
Heart Rhythm 8, 48–55.
Battistini,S.,Stenirri,S.,Piatti,M.,Gelﬁ,
C., Righetti, P. G., Rocchi, R., Gian-
nini,F.,Battistinin,N.,Guazzi,C.G.,
Faerrarri,M.,andCarrera,P.(1999).
A new CACNA1A gene mutation
in acetazolamide-responsive famil-
ial hemiplegic migraine and ataxia.
Neurology 53, 38–43.
Bendahhou,S.,Cummins,T. R.,Griggs,
R. C., Fu, Y. H., and Ptácek, L.
J. (2001). Sodium channel inac-
tivation defects are associated
with acetazolamide-exacerbated
hypokalemic periodic paralysis.
Ann. Neurol. 50, 417–420.
Bezzina, C. R., Rook, M. B., Groenewe-
gen, W. A., Herfst, L. J., van der
Wal, A. C., Lam, J., Jongsma, H. J.,
Wilde, A. A., and Mannens, M. M.
(2003). Compound heterozygosity
for mutations (W156X and R225W)
inSCN5Aassociatedwithseverecar-
diac conduction disturbances and
degenerative changes in the conduc-
tion system. Circ. Res. 92, 159–168.
Bond, E. F., and Gordon, A. M. (1993).
Insulin-induced membrane changes
in(K+)depletedratskeletalmuscle.
Am. J. Physiol. 265, C257–C265.
Bulman,D.E.,Scoggan,K.A.,vanOene,
M. D., Nicolle, M. W., Hahn, A. F.,
Tollar,L. L.,and Ebers,G. C. (1999).
Anovelsodiumchannelmutationin
a family with hypokalemic periodic
paralysis. Neurology 53, 1932–1936.
Butteriss, D. J., Ramesh, V., and
Birchall, D. (2003). Serial MRI
in a case of familial hemiplegic
migraine. Neuroradiology 45,
300–303.
Cannon, S. C. (2010). Voltage-sensor
mutations in channelopathies of
skeletal muscle. J. Physiol. (Lond.)
588, 1887–1895.
Carle, T., Lhuillier, L., Luce, S., Stren-
berg, D., Devuyst, O., Fontaine, B.,
and Tabti, N. (2006). Gating defects
of a novel Na+ channel mutant
causinghypokalemicpeiodicparaly-
sis. Biochem. Biophys. Res. Commun.
348, 653.
Carreño,O.,García-Silva,M.T.,García-
Campos, Ó., Martínez-de Aragón,
A., Cormand, B., and Macaya, A.
(2011). Acute striatal necrosis in
hemiplegic migraine with de novo
CACNA1A mutation. Headache 51,
1542–1546.
Catterall, W. A. (2010). Ion channel
voltage sensors: structure, function,
and pathophysiology. Neuron 67,
915–928.
Catterall, W. A., Kalume, F., and Oak-
ley, J. C. (2010). NaV1.1 channels
and epilepsy. J. Physiol. (Lond.) 588,
1849–1859.
Chabriat, H., Vahedi, K., Clark, C.
A., Poupon, C., Ducros, A., Denier,
C., Le Bihan, D., and Bousser,
M. G. (2000). Decreased hemi-
spheric water mobility in hemi-
plegic migraine related to mutation
of CACNA1A gene. Neurology 54,
510–512.
Chabrier, S., Monnier, N., and
Lunardi, J. (2008). Early onset
of hypokalaemic periodic paralysis
caused by a novel mutation of the
CACNA1S gene. J. Med. Genet. 45,
686–688.
Cheng, C.-J., Lin, S.-H., Lo, Y.-F., Yang,
S.-S., Hsu, Y.-J., Cannon, S. C.,
and Huang, C.-L. (2011). Identiﬁ-
cation and functional characteriza-
tion of Kir2.6 mutations associated
withnon-familialhypokalemicperi-
odic paralysis. J. Biol. Chem. 286,
27425–27435.
Chouabe, C., Neyroud, N., Richard, P.,
Denjoy, I., Hainque, B., Romey, G.,
Drici, M. D., Guicheney, P., and
Barhanin,J.(2000).Novelmutations
in KvLQT1 that affect Iks activa-
tion through interactions with Isk.
Cardiovasc. Res. 45, 971–980.
Davies, N. P., Eunson, L. H., Samuel,
M., and Hanna, M. G. (2001).
Sodium channel gene mutations in
hypokalemic periodic paralysis: an
uncommon vause in the UK. Neu-
rology 57, 1323–1325.
Dedek, K., Kunath, B., Kananura, C.,
Reuner, U., Jentsch, T. J., and Stein-
lein, O. K. (2001). Myokymia and
neonatal epiepsy caused by a muta-
tion in the voltage sensor of the
KCNQ2 K+ channel. Proc. Natl.
Acad. Sci. U.S.A. 98, 12272–12277.
Ducros, A., Denier, C., Joutel, A., Cecil-
lon,M.,Lescoat,C.,Vahedi,K.,Dar-
cel, F., Vicaut, E., Bousser, M. G.,
and Tournier-Lasserve, E. (2001).
The clinical spectrum of familial
hemiplegicmigraineassociatedwith
mutations in a neuronal calcium
channel. N .E n gl .J .M e d .345,17–24.
Dumaine, R., Wang, Q., Keating, M.
T., Hartmann, H. A., Schwartz, P.
J., Brown, A. M., and Kirsch, G.
E. (1996). Multiple mechanisms of
Na+ channel – linked long-QT syn-
drome. Circ. Res. 78, 916–924.
Escayg, A., and Goldin, A. L.
(2010). Sodium channel SCN1A
and epilepsy: mutations and
mechanisms. Epilepsia 51,
1650–1168.
Escayg, A., MacDonald, B. T., Meisler,
M. H.,Baulac,S.,Huberfeld,G.,An-
Gourﬁnkel, I., Brice, A., LeGuern,
E., Moulard, B., Chaigne, D., Buresi,
C., and Malafosse, A. (2000). Muta-
tions of SCN1A, encoding a neu-
ronal sodium channel, in two fam-
ilies with GEFS+2. Nat. Genet. 24,
343–345.
Fan,Z.,George,A. L. Jr.,Kyle,J.W.,and
Makielski, J. C. (1996). Two human
paramyotonia congenital mutations
have opposite effects on lidocaine
block of Na+ channels expressed in
a mammalian cell line. J. Physiol.
(Lond.) 496, 275–286.
Featherstone, D. E., Fujimoto, E., and
Ruben,P.C.(1998).Adefectinskele-
tal muscle sodium channel deacti-
vation exacerbates hyperexcitability
in human paramyotonia congenita.
J. Physiol. (Lond.) 506, 627–638.
Fodstad, H., Swan, H., Laitinen, P.,
Piippo, K., Paavonen, K., Viitasalo,
M., Toivonen, L., and Kontula, K.
(2004). Four potassium channel
mutations account for 73% of the
genetic spectrum underlying long-
QT syndrome (LQTS) and provide
evidence for a strong founder effect
in Finland. Ann. Med. 36, 53–63.
Francis, D. G., Rybalchenko, V., Struyk,
A., and Cannon, S. C. (2011). Leaky
sodium channels from voltage sen-
sor mutations in periodic paralysis,
butnotparamyotonia.Neurology 76,
1635–1641.
Franqueza,L.,Lin,M.,Shen,J.,Splawski,
I., Keating, M. T., and Sanguinetti,
M. C. (1999). Long QT syndrome-
associated mutations in the S4-S5
linker of KvLQT1 potassium chan-
nels modify gating and interaction
with minK subunits. J. Biol. Chem.
274, 21063–21070. [Erratum in: J.
Biol. Chem. 274, 25188].
Friend, K. L., Crimmins, D., Phan, T.
G., Sue, C. M., Colley, A., Fung, V.
S., Morris, J. G., Sutherland, G. R.,
and Richards, R. I. (1999). Detec-
tion of a novel missense mutation
and second recurrent mutation in
the CACNA1A gene in individuals
with EA-2 and FHM. Hum. Genet.
105, 261–265.
Frigo, G., Rampazzo, A., Bauce, B.,
Pilichou, K., Beffagna, G., Danieli,
G. A., Nava, A., and Martini, B.
(2007). Homozygous SCN5A muta-
tion in Brugada syndrome with
monomorphic ventricular tachycar-
dia and structural heart abnormali-
ties. Europace 9, 391–397.
Gamal El-Din, T. M., Heldstab, H.,
Lehmann, C., and Greeff, N. G.
(2010). Double gaps along Shaker
S4 demonstrate omega currents at
three different closed states. Chan-
nels (Austin) 4, 93–100.
Groome, J. R., Fujimoto, E., George, A.
L., and Ruben, P. C. (1999). Dif-
ferential effects of homologous S4
mutations in human skeletal mus-
cle sodium channels on deactiva-
tion gating from open and inacti-
vated states. J. Physiol. (Lond.) 516,
687–698.
Groome, J. R., and Winston, V. (2012).
Voltage sensor module in NaV1.4:
S1-S3 charges regulate fast inactiva-
tion. Biophys. Soc. Abstr. 1655, Pos
B425.
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies June 2012 | Volume 3 | Article 112 | 12Jurkat-Rott et al. Omega pores in channelopathies
Hans, M., Luvisetto, S., Williams, M.
E., Spagnolo, M., Urrutia, A., Tot-
tene, A., Brust, P. F., Johnson, E.
C., Harpold, M. M., Stauderman, K.
A., and Pietrobon, D. (1999). Func-
tional consequences of mutations in
thehumanalpha1Acalciumchannel
subunitlinkedtofamilialhemiplegic
migraine.J.Neurosci.19,1610–1619.
Heine,R.,Pika,U.,andLehmann-Horn,
F. (1993). A novel SCN4A mutation
causingmyotoniaaggravatedbycold
and potassium. Hum. Mol. Genet. 2,
1349–1353.
Holzherr, B. D., Groome, J. R., Fauler,
M.,Nied,E.,Lehmann-Horn,F.,and
Jurkat-Rott, K. (2010). Characteri-
zation of a novel hNaV1.4 mutation
causinghypokalemicperiodicparal-
ysis. Biophys. Soc. Abstr. LB201, Pos
L201.
Hong, D., Luan, X., Chen, B., Zheng,
R., Zhang, W., Wang, Z., and Yuan,
Y. (2010). Both hypokalaemic and
normokalaemicperiodicparalysisin
different members of a single fam-
ily with novel R1129Q mutation in
SCN4A gene. J. Neurol. Neurosurg.
Psychiatr. 81, 703–704.
Iizuka, T., Sakai, F., Suzuki, K., Igarashi,
H., and Suzuki, N. (2006). Implica-
tionofaugmentedvasogenicleakage
in the mechanism of persistent aura
in sporadic hemiplegic migraine.
Cephalgia 26, 332–335.
Itoh, T., Tanaka, T., Nagai, R., Kamiya,
T., Sawayama, T., Nakayama, T.,
Tomoike,H.,Sakurada,H.,Yazaki,Y.,
and Nakamura, Y. (1998). Genomic
organization and mutational analy-
sis of HERG, a gene responsible for
familial long QT syndrome. Hum.
Genet. 102, 435–439.
Jurkat-Rott, K., Holzherr, B., Fauler,
M., and Lehmann-Horn, F. (2010).
Sodium channelopathies of skele-
tal muscle result from gain or
loss of function. Pﬂugers Arch. 460,
239–248.
Jurkat-Rott, K., and Lehmann-Horn,
F. (2007). Do hyperpolarization-
induced proton currents contribute
to the pathogenesis of hypokalemic
periodic paralysis, a voltage sensor
channelopathy? J. Gen. Physiol. 130,
1–5.
Jurkat-Rott, K., Lehmann-Horn, F.,
Elbaz, A., Heine, R., Gregg, R. G.,
Hogan, K., Powers, P. A., Lapie,
P., Vale-Santos, J. E., Weissenbach,
J., and Fontaine, B. (1994). A
calcium channel mutation caus-
ing hypokalemic periodic paralysis.
Hum. Mol. Genet. 3, 1415–1419.
Jurkat-Rott, K., Mitrovic, N., and
Lehmann-Horn, F. (2000). Voltage-
sensor sodium channel mutations
cause hypokalemic periodic
paralysis type 2 by enhanced
inactivation and reduced current.
Proc. Natl. Acad. Sci. U.S.A. 97,
9549–9554.
Jurkat-Rott,K.,Uetz,U.,Pika-Hartlaub,
U., Powell, J., Fontaine, B., Melzer,
W., and Lehmann-Horn, F. (1998).
Calcium currents and transients of
native and heterologously expressed
mutant skeletal muscle DHP recep-
tor alpha1 subunits (R528H). FEBS
Lett. 423, 198–204.
Jurkat-Rott, K., Weber, M. A., Fauler,
M., Guo, X. H., Holzherr, B. D.,
Paczulla, A., Nordsborg, N., Joechle,
W., and Lehmann-Horn, F. (2009).
K+-dependent paradoxical mem-
branedepolarizationandNa+over-
load, major and reversible contrib-
utors to weakness by ion channel
leaks. Proc. Natl. Acad. Sci. U.S.A.
106, 4036–4041.
Kahlig,K.M.,Lepist,I.,Leung,K.,Raja-
mani, S., and George, A. L. (2010).
Ranolazine selectively blocks per-
sistent current evoked by epilepsy-
associated Naν1.1 mutations. Br. J.
Pharmacol. 161, 1414–1426.
Kahlig, K. M., Misra, S. N., and George,
A. L. Jr. (2006). Impaired inac-
tivation gate stabilization predicts
increased persistent current for an
epilepsy-associated SCN1A muta-
tion. J. Neurosci. 26, 10958–10966.
Kim, J. B., Kim, M. H., Lee, S. J.,
Kim, D. J., and Lee, B. C. (2007).
The genotype and clinical pheno-
type of Korean patients with famil-
ialhypokalemicperiodicparalysis.J.
Korean Med. Sci. 22, 946–951.
Kraus, R. L., Sinnegger, M. J., Gloss-
mann, H., Hering, S., and Striess-
nig, J. (1998). Familial hemiplegic
migrainemutationschangealpha1A
Ca2+ channel kinetics. J. Biol.
Chem. 273, 5586–5590.
Kraus, R. L., Sinnegger, M. J., Koschak,
A., Glossmann, H., Stenirri, S., Car-
rera, P., and Striessnig, J. (2000).
Three new familial hemiplegic
migraine mutants affect P/Q-type
Ca(2+) channel kinetics. J. Biol.
Chem. 275, 9239–9243.
Kuzmenkin,A., Hang, C., Kuzmenkina,
E., and Jurkat-Rott, K. (2007). Gat-
ing of the HypoPP-1 mutations: I.
Mutant-speciﬁc effects and cooper-
ativity. Pﬂugers Arch. 454, 495–505.
Kuzmenkin, A., Muncan, V., Jurkat-
Rott, K., Hang, C., Lerche, H.,
Lehmann-Horn,F.,andMitrovic,N.
(2002). Enhanced inactivation and
pHsensitivityofNa+channelmuta-
tionscausinghypokalaemicperiodic
paralysistypeII.Brain125,835–843.
Lapie, P., Goudet, C., Nargeot, J.,
Fontaine, B., and Lory, P. (1996).
Electrophysiological properties of
the hypokalaemic periodic paraly-
sis mutation (R528H) of the skeletal
musclealpha1ssubunitasexpressed
in mouse L cells. FEBS Lett. 382,
244–248.
Lee, S. C., Kim, H. S., Park, Y. E., Choi,
Y. C., Park, K. H., and Kim, D. S.
(2009). Clinical diversity of SCN4A-
mutation-associated skeletal muscle
sodium channelopathy. J. Clin. Neu-
rol. 5, 186–191.
Lehmann-Horn, F., and Jurkat-Rott, K.
(1999). Voltage-gated ion channels
and hereditary disease. Physiol. Rev.
79, 1317–1371.
Lehmann-Horn, F., Rüdel, R., and
Ricker,K.(1987).Membranedefects
in paramyotonia congenita (Eulen-
burg). Muscle Nerve 10, 633–641.
Lehmann-Horn, F., Sipos, I., Jurkat-
Rott, K., Heine, R., Brinkmeier, H.,
Fontaine, B., Kovacs, L., and Melzer,
W. (1995). Altered calcium cur-
rents in human hypokalemic peri-
odic paralysis myotubes expressing
mutant L-type calcium channels.
Soc. Gen. Physiol. Ser. 50, 101–113.
Lerche, H., Heine, R., Pika, U., George,
A. L., Mitrovic, N., Browatzki, M.,
Weiss, T., Bastide-Rivet, M., Franke,
C., LoMonaco, M., Ricker, K., and
Lehmann-Horn, F. (1993). Human
sodium channel myotonia: slowed
channelinactivationduetosubstitu-
tions for a glycine within the III/IV
linker. J. Physiol. (Lond.) 470,13–22.
Lerche, H., Mitrovic, N., Dubowitz,
V., and Lehmann-Horn, F. (1996).
Paramyotonia congenita: the
R1448P Na+ channel mutation in
adult human skeletal muscle. Ann.
Neurol. 39, 599–608.
Lossin, C., Rhodes, T. H., Desai, R. R.,
Vanoye, C. G., Wang, D., Carniciu,
S., Devinsky, O., and George, A. L.
Jr. (2003). Epilepsy-associated dys-
function in the voltage-gated neu-
ronal sodium channel SCN1A. J.
Neurosci. 23, 11289–11295.
Lupoglazoff, J. M., Denjoy, I., Vil-
lain, E., Fressart, V., Simon, F.,
Bozio, A., Berthet, M., Benam-
mar, N., Hainque, B., and Guich-
eney, P. (2004). Long QT syndrome
in neonates: conduction disorders
associated with HERG mutations
and sinus bradycardia with KCNQ1
mutations. J. Am. Coll. Cardiol. 43,
826–830.
Makita, N., Shirai, N., Magashima, M.,
Matsuoka, R.,Yamada,Y., Tohse, N.,
andKitabatake,A.(1998).Adenovo
missense mutation of human car-
diacNa(+)channelexhibitingnovel
molecular mechanism of long QT
syndrome. FEBS Lett. 423, 5–9.
Maljevic, S., Wuttke, T. V., and Lerche,
H. (2008). Nervous system Kv7
disorders: breakdown of a sub-
threshold brake. J. Physiol. (Lond.)
586, 1791–1801.
Martin, M. S., Dutt, K., Papale, L. A.,
Dubé,C. M.,Dutton,S. B.,de Haan,
G., Shankar, A., Tuﬁk, S., Meisler,
M. H., Baram, T. Z., Goldin, A. L.,
and Escayg,A. (2010). Altered func-
tion of the SCN1A voltage-gated
sodium channel leads to gamma-
aminobutyric acid-ergic (GABAer-
gic) interneuron abnormalities. J.
Biol. Chem. 285, 9823–9834.
Matthews,E.,andHanna,M.G.(2010).
Muscle channelopathies: does the
predicted gating pore offer new
treatment insights for hypokalemic
periodicparalysis?J.Physiol.(Lond.)
588, 1879–1886.
Matthews, E., Labrum, R., Sweeney, M.
G., Sud, R., Haworth, A., Chinnery,
P. F., Meola, G., Schorge, S., Kull-
mann, D. M., Davis, M. B., and
Hanna,M. G. (2009).Voltage sensor
charge loss accounts for most cases
of hypokalemic periodic paralysis.
Neurology 72, 1544–1547.
Matthews, E., Tan, S. V., Fialho, D.,
Sweeney, M. G., Sud, R., Haworth,
A., Stanley, E., Cea, G., Davis, M. B.,
Hanna, M. G. (2008). What causes
paramyotonia in the United King-
dom? Common and new SCN4A
mutations revealed. Neurology 70,
50–53.
Miceli, F., Vargas, E., Bezanilla, F.,
and Taglialatela, M. (2012). Gat-
ing currents from K(v)7 chan-
nels carrying neuronal hyperex-
citability mutations in the voltage-
sensing domain. Biophys. J. 102,
1372–1382.
Millat, G., Chevalier, P., Restier-Miron,
L., Da Costa, A., Bouvagnet, P.,
Kugener, B., Fayol, L., Gonzàlez
Armengod, C., Oddou, B., Chana-
vat, V., Froidefond, E., Perraudin,
R., Rousson, R., and Rodriguez-
Lafrasse, C. (2006). Spectrum of
pathogenic mutations and associ-
ated polymorphisms in a cohort
of 44 unrelated patients with long
QT syndrome. Clin. Genet. 70,
214–227.
Mitrovic,N.,George,A.L.Jr.,Rüdel,R.,
Lehmann-Horn, F., and Lerche, H.
(1999). Mutant channels contribute
<50% to Na+ current in paramy-
otonia congenita muscle. Brain 122,
1085–1092.
Mohammad-Panah,R.,Demolombe,S.,
Neyroud, N., Guicheney, P., Kyndt,
F., van den Hoff, M., Baró, I., and
Escande, D. (1999). Mutations in
a dominant-negative isoform cor-
relate with phenotype in inherited
cardiac arrhythmias. A m .J .H u m .
Genet. 64, 1015–1023.
www.frontiersin.org June 2012 | Volume 3 | Article 112 | 13Jurkat-Rott et al. Omega pores in channelopathies
Morrill, J. A., Brown, R. H. Jr., and
Cannon, S. C. (1998). Gating of the
L-type Ca channel in human skele-
tal myotubes: an activation defect
caused by the hypokalemic peri-
odic paralysis mutation R528H. J.
Neurosci. 18, 10320–10334.
Morrill, J. A., and Cannon, S. C.
(1999). Effects of mutations caus-
ing hypokalaemic periodic paralysis
on the skeletal muscle L-type Ca2+
channel expressed in Xenopus lae-
vis oocytes. J. Physiol. (Lond.) 520,
321–336.
Mullen, S. A., and Scheffer, I. E.
(2009). Translational research in
epilepsy genetics. Arch. Neurol. 66,
21–26.
Nagel, A. M., Amarteiﬁo, E., Lehmann-
Horn, F., Jurkat-Rott, K., Semmler,
W., Schad, L. R., and Weber, M.
A. (2011). 3 Tesla sodium inver-
sion recovery magnetic resonance
imaging allows improved visu-
alization of intracellular sodium
content changes in muscular chan-
nelopathies. Invest. Radiol. 46,
759–766.
Nakajima, T., Furukawa, T., Hirano, Y.,
Tanaka, T., Sakurada, H., Takahashi,
T., Nagai, R., Itoh, T., Katayama,
Y., Nakamura, Y., and Hiraoka, M.
(1999). Voltage-shift of the current
activation in HERG S4 mutation
(R534C) in LQT2. Cardiovasc. Res.
44, 283–293.
Nielles-Vallespin,S.,Weber,M.A.,Bock,
M., Bongers, A., Speier, P., Combs,
S. E., Wöhrle, J., Lehmann-Horn, F.,
Essig, M., and Schad, L. R. (2007).
3D radial projection technique with
ultrashort echo times for sodium
MRI: clinical applications in human
brain and skeletal muscle. Magn.
Reson. Med. 57, 74–81.
Oakley, J. C., Kalume, F., and Cat-
terall, W. A. (2011). Insights into
pathophysiology and therapy from a
mouse model of Dravet syndrome.
Epilepsia 52, 59–61.
Ophoff, R. A., Terwindt, G. M., Ver-
gouwe, M. N., van Eijk, R., Oefner,
P. J.,Hoffman,S. M. G.,Lamerdin,J.
E.,Mohrenweiser,H.W.,Bulman,D.
E., Ferrari, M., Haan, J., Lindhout,
D., van Ommen, G.-J. B., Hofker,
M. H., Ferrari, M. D., and Frants,
R. R. (1996). Familial hemiplegic
migraine and episodic ataxia type-
2 are caused by mutations in the
Ca(2+) channel gene CACNL1A4.
Cell 87, 543–552.
Plaster, N. M., Tawil, R., Tristani-
Firouzi, M., Canun, S., Bendahhou,
S., Tsunoda, A., Donaldson, M. R.,
Iannaccone, S. T., Brunt, E., Barohn,
R., Clark, J., Deymeer, F., George, A.
L. Jr., Fish, F. A., Hahn, A., Nitu, A.,
Ozdemir, C., Serdaroglu, P., Subra-
mony, S. H., Wolfe, G., Fu, Y.-H.,
and Ptacek, L. J. (2001). Mutations
in Kir2.1 cause the developmental
and episodic electrical phenotypes
of Anderson’s syndrome. Cell 105,
511–519.
Ptacek, L. J., George, A. L.Jr., Barchi, R.
L.,Griggs,R. C.,Riggs,J. E.,Robert-
son, M., and Leppert, M. F. (1992).
Mutations in an S4 segment of the
adult skeletal muscle sodium chan-
nel cause paramyotonia congenita.
Neuron 8, 891–897.
Ptacek, L. J., Tawil, R., Griggs, R.
C., Engel, A. G., Layzer, R. B.,
Kwiecinski, H., McManis, P. G.,
Santiago, L., Moore, M., Fouad,
G., Bradley, P., and Leppert, M. F.
(1994). Dihydropyridine receptor
mutations cause hypokalemic
periodic paralysis. Cell 77,
863–868.
Resnick, J. S., Engel, W. K., Griggs, R.
C., and Stam,A. C. (1968). Acetazo-
lamide prophylaxis in hypokalemic
periodic paralysis. N .E n g l .J .M e d .
278, 582–586.
Rhodes, T. H., Lossin, C., Vanoye,
C. G., Wang, D. W., and George,
A. L. Jr. (2004). Noninactivating
voltage-gated sodium channels in
severemyoclonicepilepsyofinfancy.
Proc. Natl. Acad. Sci. U.S.A. 101,
11147–11152.
Ruan,Y., Liu, N., Bloise, R., Napolitano,
C., and Priori, S. G. (2007). Gat-
ing properties of SCN5A mutations
and the response to mexiletine in
long-QT syndrome type 3 patients.
Circulation 116, 1137–1144.
Ruff, R. L. (1999). Insulin acts in
hypokalemic periodic paralysis by
reducing inward rectiﬁer K current.
Neurology 53, 1556.
Russell, M. B., and Ducros, A. (2011).
Sporadic and familial hemiplegic
migraine: pathophysiological mech-
anisms,clinical characteristics,diag-
nosis,andmanagement.LancetNeu-
rol. 10, 457–470.
Ryan, D. P., da Silva, M. R. D., Soong,
T. W., Fontaine, B., Donaldson, M.
R., Kung, A. W. C., Jongjaroen-
prasert, W., Liang, M. C., Khoo,
D. H. C., Cheah, J. S., Ho, S. C.,
Bernstein, H. S., Maciel, R. M. B.,
Brown, R. H. Jr., and Ptacek, L.
J. (2010). Mutations in potassium
channel Kir2.6 cause susceptibility
to thyrotoxic hypokalemic periodic
paralysis. Cell 140, 88–98.
Scott, R. C., King, M. D., Gadian, D.
G., Neville, B. G., and Connelly, A.
(2003). Hippocampal abnormalities
after prolonged febrile convulsion: a
longitudinal MRI study. Brain 126,
2551–2557.
Scott, R. C., King, M. D., Gadian, D.
G., Neville, B. G., and Connelly, A.
(2006). Prolonged febrile seizures
are associated with hippocampal
vasogenicedemaanddevelopmental
changes. Epilepsia 47, 1493–1498.
Sokol, D. K., Demyer, W. E., Edwards-
Brown, M., Sanders, S., and Garg, B.
(2003). From swelling to sclerosis:
acute change in mesial hippocam-
pus after prolonged febrile seizure.
Seizure 12, 237–240.
Sokolov,S.,Scheuer,T.,andCatterall,W.
A. (2005). Ion permeation through
a voltage- sensitive gating pore in
brain sodium channels having volt-
age sensor mutations. Neuron 47,
183–189.
Sokolov,S.,Scheuer,T.,andCatterall,W.
A. (2007). Gating pore current in an
inherited ion channelopathy. Nature
446, 76–78.
Sokolov,S.,Scheuer,T.,andCatterall,W.
A. (2008). Depolarization-activated
gating pore current conducted
by mutant sodium channels in
potassium-sensitive normokalemic
periodic paralysis. Proc. Natl. Acad.
Sci. U.S.A. 105, 19980–19985.
Sokolov, S., Scheuer, T., and Catter-
all, W. A. (2010). Ion permeation
and block of the gating pore in the
voltage sensor of NaV1.4 channels
with hypokalemic periodic paraly-
sis mutations. J. Gen. Physiol. 136,
225–236.
Spampanato, J., Escayg, A., Meisler,
M. H., and Goldin, A. L. (2001).
Functional effects of two voltage-
gated sodium channel mutations
that cause generalized epilepsy with
febrile seizures plus type 2. J. Neu-
rosci. 21, 7481–7490.
Splawski, I., Shen, J., Timothy, K. W.,
Lehmann, M. H., Priori, S., Robin-
son, J. L., Moss, A. J., Schwartz, P.
J., Towbin, J. A., Vincent, G. M.,
andKeating,M.T.(2000).Spectrum
of mutations in long-QT syndrome
genes. KVLQT1, HERG, SCN5A,
KCNE1, and KCNE2. Circulation
102, 1178–1185.
Starace, D. M., and Bezanilla, F. (2001).
Histidine scanning mutagenesis of
basic residues of the S4 segment
of the Shaker K+ channel. J. Gen.
Physiol. 117, 469–490.
Starace, D. M., and Bezanilla, F. (2004).
A proton pore in a potassium chan-
nel voltage sensor reveals a focused
electric ﬁeld. Nature 427, 548–553.
Starace,D.M.,Stefani,E.,andBezanilla,
F.(1997).Voltage-dependentproton
transport by the voltage sensor of
the Shaker K+ channel. Neuron 19,
1319–1327.
Struyk,A. F., and Cannon, S. C. (2007).
AN a + channel mutation linked
to hypokalemic periodic paralysis
exposes a proton-selective gating
pore. J. Gen. Physiol. 130, 11–20.
Struyk, A. F., and Cannon, S. C.
(2008). Paradoxical depolarization
of Ba2+-treated muscle exposed to
low extracellular K+: insights into
resting potential abnormalities in
hypokalemic paralysis. Muscle Nerve
37, 326–337.
Struyk, A. F., Markin, V. S., Francis,
D., and Cannon, S. (2008). Gat-
ing pore currents in DIIS4 muta-
tions of NaV1.4 associated with
periodic paralysis: saturation of ion
ﬂux and implications for disease
pathogenesis. J. Gen. Physiol. 132,
447–464.
Struyk, A. F., Scoggan, K. A., Bul-
man, D. E., and Cannon, S. C.
(2000). The human skeletal muscle
Na channel mutation R669H asso-
ciated with hypokalemic periodic
paralysisenhancesslowinactivation.
J. Neurosci. 20, 8610–8617.
Tombola, F., Pathak, M. M., and
Isacoff, E. Y. (2005). Voltage-
sensing arginines in a potassium
channel permeate and occlude
cation-selective pores. Neuron 45,
379–388.
Tonelli, A., D’Angelo, M. G., Salati, R.,
Villa, L., Germinasi, C., Frattini, T.,
Meola, G., Turconi, A. C., Bresolin,
N., and Bassi, M. T. (2006). Early
onset,non ﬂuctuating spinocerebel-
larataxiaandanovelmissensemuta-
tion in CACNA1A gene. J. Neurol.
Sci. 241, 13–17.
Tricarico, D., and Camerino, D. C.
(2011). Recent advances in the
pathogenesis and drug action in
periodic paralyses and related chan-
nelopathies. Front. Pharmacol. 2:8.
doi:10.3389/fphar.2011.00008
Tricarico, D., Pierno, S., Mallamaci, R.,
Brigiani, G. S., Capriulo, R., San-
toro,G.,andCamerino,D.C.(1998).
The biophysical and pharmacolog-
ical characteristics of skeletal mus-
cle ATP-sensitive K+ channels are
modiﬁed in K+-depleted rat, an
animal model of hypokalemic peri-
odic paralysis. Mol. Pharmacol. 54,
197–206.
vandenMaagdenberg,A.M.,Pietrobon,
D., Pizzorusso, T., Kaja, S., Broos, L.
A.,Cesetti,T.,van deVen,R. C.,Tot-
tene, A., van der Kaa, J., Plomp, J.
J., Frants, R. R., and Ferrari, M. D.
(2004).ACacna1aknockinmigraine
mousemodelwithincreasedsuscep-
tibility to cortical spreading depres-
sion. Neuron 41, 701–710.
Vanoye, C. G., Lossin, C., Rhodes, T.
H., and George, A. L. Jr. (2006).
Single-channel properties of human
NaV1.1 and mechanism of channel
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies June 2012 | Volume 3 | Article 112 | 14Jurkat-Rott et al. Omega pores in channelopathies
dysfunction in SCN1A-associated
epilepsy. J. Gen. Physiol. 127,
1–14.
Vicart, S., Sternberg, D., Fournier, E.,
Ochsner, F., Laforet, P., Kuntzer,
T., Eymard, B., Hainque, B.,
and Fontaine, B. (2004). New
mutations of SCN4A cause a
potassium-sensitive normokalemic
periodic paralysis. Neurology 63,
2120–2127.
Wallinga, W., Meijer, S. L., Alberink,
M. J., Vliek, M., Wienk, E. D., and
Ypey,D. L. (1999). Modelling action
potentials and membrane cur-
rents of mammalian skeletal mus-
cle ﬁbres in coherence with potas-
sium concentration changes in the
T-tubularsystem.Eur.Biophys.J.28,
317–329.
Wolf, P. (2011). Acute drug adminis-
tration in epilepsy: a review. CNS
Neurosci. Ther. 17, 442–448.
Wu,F.,Mi,W.,Burns,D.K.,Fu,Y.,Gray,
H. F., Struyk, A. F., and Cannon,
S. C. (2011). A sodium channel
knockin mutant (NaV1.4-R669H)
mouse model of hypokalemic peri-
odic paralysis. J. Clin. Invest. 121,
4082–4094.
Wu, L., Wu, W., Yan, G., Wang, X., and
Liu, J. (2008). The construction and
preliminary investigation of the cell
model of a novel mutation R675Q
in the SCN4A gene identiﬁed in a
Chinese family with normokalemic
periodic paralysis. Zhonghua Yi
Xue Yi Chuan Xue Za Zhi 25,
629–632.
Wuttke, T. V., Jurkat-Rott, K., Paulus,
W., Garncarek, M., Lehmann-
Horn, F., and Lerche, H. (2007).
Peripehral nerve hyperexcitabil-
ity due to dominant-negative
KCNQ2 mutations. Neurology 69,
2045–2053.
Yamagishi, H., Furutani, M., Kamisago,
M., Morikawa, Y., Kojima, Y., Hino,
Y., Furutani, Y., Kimura, M., Ima-
mura, S., Takao, A., Momma, K.,
and Matsuoka,R. (1998). A de novo
missense mutation (R1623Q) of the
SCN5A gene in a Japanese girl with
sporadic long QT sydrome. Muta-
tions in brief no. 140. Online. Hum.
Mutat. 11, 481.
Yang, N., Ji, S., Zhou, M., Ptacek, L.
J., Barchi, R. L., Horn, R., and
George, A. L. Jr. (1994). Sodium
channel mutations in paramy-
otonia congenita exhibit similar
biophysical phenotypes in vitro.
Proc. Natl. Acad. Sci. U.S.A. 91,
12785–12789.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential
conﬂict of interest.
Received:22April2012;accepted:23May
2012; published online: 11 June 2012.
Citation: Jurkat-Rott K, Groome J and
Lehmann-Horn F (2012) Pathophysio-
logicalroleofomegaporecurrentinchan-
nelopathies. Front. Pharmacol. 3:112.
doi: 10.3389/fphar.2012.00112
This article was submitted to Frontiers
in Pharmacology of Ion Channels and
Channelopathies, a specialty of Frontiers
in Pharmacology.
Copyright © 2012 Jurkat-Rott, Groome
and Lehmann-Horn. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
Non Commercial License, which per-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
www.frontiersin.org June 2012 | Volume 3 | Article 112 | 15Jurkat-Rott et al. Omega pores in channelopathies
APPENDIX
PATHOGENESIS MODEL – CATASTROPHE ON THE CUSP
Using catastrophe theory, the effects of an omega current were simulated in a one-compartment computer model of skeletal mus-
cle ﬁbers. Both changes of ion concentrations and consecutive water shifts were considered. The size of the T-tubular system was
accounted for by a speciﬁc factor. It was not considered a separate compartment since the low-resistance T-tubular openings justiﬁed
the assumption of an equilibrium. Parameters of the catastrophe model are given in Table 2; notations and abbreviations at the end of
the Appendix.
The membrane was equipped with the following conductances: a background Na+ leak conductance (gNaL), the omega pore con-
ductance (gleak), a voltage-gated Na+ (gNaV) and K+ (gKv) conductance, an inward-rectifying K+ (gIR) and a voltage-dependent
Cl− (gCl) conductance, a hydraulic conductivity (LH), and a Na+/K+ pump ﬂux (Jp). The model was based on the charge-difference
approach (3) in which the membrane potential E is calculated from the amount of charges in the intracellular compartment Qi and
the membrane area Am:
E =
Qi
¯ cm · Am
with Am = 4 · η ·
Vi
Df
Qi = F ·
 
ion
nion · zion ion ∈ {Na, K, Cl, Fix, S}
V i wasthecellvolume,Df theﬁberdiameterand ηafactorcorrectingthesizeof theT-tubularmembrane.Thecellwasonlypermeable
for Na, K, Cl, and H2O. Fix are intracellular anions (e.g., proteins, phosphates), which – in this model – cannot pass through the
membrane. Their overall charge valence zFix is set to −1.3. This was necessary to avoid very negative membrane potentials at low
potassium concentrations. S are the positive charged ions, that block inward-rectifying K+ channels from inside upon depolarization.
Its valence zS is set to +2, so they represent Mg2+. Multiple positively charged polyamines that increase the strength of rectiﬁcation
were not considered.
The amounts of ions and water in the cell n are state variables in this model. They are integrated over time by numerically solving
the differential equations that describe their ﬂuxes J:
ns =ˆ ns +
t  
0
Js · dt s ∈ {Na,K,Cl,H 2O}
Js =
dns
dt
=
 
c
Jc
s +
 
p
J
p
s
c ∈
 
NaV,K V,K ir, ClC,Aqua
 
p ∈
 
Na/K − pump
 
The ﬂuxes of ions through channels Jc
s and water through an aquaporin J
Aqua
H2O (modeled by a simple hydraulic conductivity) are
computed by the following equations:
Jc
ion =− F−1 · gc
ion · (E − Eion)
ion ∈
 
Na+,K +,C l − 
c ∈
 
NaL, Leak, NaV, KV, Kir, ClC
 
J
Aqua
H2O = LH ·ˆ cH2O · ΔΠ
Thedrivingforcesfortheﬂuxesweretheelectrochemicalgradients(E−Eion)forionsortheosmoticpressuredifference ΔΠforwater:
Eion =
R · T
zion · F
· ln
 
cion
e
cion
i
 
ΔΠ = R · T ·
 
sol
 
csol
i − csol
e
 
sol ∈ {Na, K, Cl, Fix,S}
The Na/K pump was modeled by
Jp = ˆ Jp ·
 
1 + KmK
 
cK +
e
 −2
·
 
1 + KmNa
 
cNa +
i
 −3
,J
p
Na + =− 3 · Jp and J
p
K + = 2 · Jp
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The parameters KmK and KmNa were taken from Wallinga et al. (1999). The maximum pump ﬂux ˆ Jp was chosen to get an intracellular
Na+ concentration cNa+
i of 15mM at control conditions. Intracellular ion concentrations were calculated from the cell volume V i and
the amount of ions:
Vi =
 
s
ns
¯ cH2O
,s∈ {Na, K, Cl, Fix,H2O}
cion
i =
nion
Vi
,i o n∈ {Na, K, Cl, Fix}
The voltage-gated Na+ (NaV),K+ (KV),and Cl− (ClC1) conductances were based on the Hodgkin–Huxley type formalism; identiﬁers
had their classical meaning. The equations taken from Wallinga et al. (1999) are given here for completeness:
gNa+
NaV =ˆ gNaV · m3 · h · S, gK+
KV =ˆ gKV · n4 · hK and gCl−
ClC =ˆ gClC · a4
The gating variables m, h, S (NaV slow inactivation), n, and hK (inactivation of KV) were state variables and deﬁned by the following
differential equations
dy
dt
= αy ·
 
1 − y
 
− βy · yy∈ {m, n, h}
αm =
ˆ αm ·
 
E − ˆ Em
 
1 − e
−
 
E−ˆ Em
  
Kαm
and βm = ˆ βm · e
−
 
E−ˆ Em
  
Kβm
αh = ˆ αh · e
−
 
E−ˆ Eh
  
Kαh and βh =
ˆ βh
1 + e
−
 
E−ˆ Eh
  
Kβh
dS
dt
=
S∞ − S
τS
, τS =
60
0.2 + 5.65 ·
 
(E + 90)
 
100
 2 and S∞ =
1
1 + e
 
E−ˆ ES
  
AS
αn =
ˆ αn ·
 
E − ˆ En
 
1 − e
−
 
E−ˆ En
  
Kαn
and βn = ˆ βn · e
−
 
E−ˆ En
  
Kβn
dhK
dt
=
hK∞ − hK
τhK
, τhK = e
−
 
E−EhK
  
KhK and hK∞ =
1
1 + e
 
E−ˆ EhK
  
AhK
The gating variable of ClC1 was assumed to reach the steady-state instantaneously
a =
1
1 + e
 
E−ˆ Ea
  
Aa
For the inward-rectifying potassium channels the same model as in Wallinga et al. (1999) was used, parameters were chosen to get
appropriate values for the limit points at control conditions and a resting conductivity at cK+
e = 3.5 mM of 41μS/cm2. The equations
were:
gK+
IR = g 
IR · y , g 
IR =
ˆ gIR ·
 
cK+
R
 2
KK+
IR +
 
cK+
R
 2 , cK+
R = cK+
e · e−δEK+F
 
RT
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y = 1 −
⎡
⎢
⎣1 +
KS
IR
cS
i · e2(1−δ)EF/RT ·
⎛
⎜
⎝1 +
 
cK+
R
 2
KK+
IR
⎞
⎟
⎠
⎤
⎥
⎦
−1
The constant background sodium leak conductance was then adapted to reach a K+ to Na+ permeability ratio between 0.01 and 0.02
and a membrane potential of approximately –86mV (at cK+
e = 3.5 mM).
For modeling the H+ leak conductance, it was assumed – based on the 31P MR spectroscopy measurements (Jurkat-Rott et al.,
2009) – that the H+ equilibrium potential was constant and further, that every H+ was exchanged by one Na+ ion, presumably by a
Na+/H+ exchanger. Thus the omega current was treated as a sodium current (indirectly) driven by the electrochemical gradient for
protons. Its conductance was modeled as a pore with a voltage-dependent open probability that follows a Boltzmann distribution. The
equation
gomega =ˆ gomega ·
 
1 + e
E−ˆ Eleak
 
Aleak
 −1
was ﬁtted to the HypoPP muscle ﬁber results. The Na+ ﬂux (indirectly) mediated by the omega pore was calculated by
JNa+
omega =− F−1 · gomega ·
 
E − EH+
 
with EH+ =
R · T
F
· ln
 
10pHi
10pHe
 
The model was implemented in MatLab Version 7.3 (The Mathworks, Inc.). Initial-value problems were solved with ODE15s, a solver
for sets of stiff ordinary differential equations. Then bifurcation analysis was done by using the continuation routines of the toolbox
CL_MATCONTVersion 2.4.
NOTATIONS AND ABBREVIATIONS
Indices
Aqua water channel
c channel like voltage-gated Na+ channel, voltage-gated K+ channel
ClC1 voltage-dependent Cl− channel
e extracellular
f ﬁber
i intracellular
ion Ion: Na+,K +,C l −
IR inwardly rectifying K+ channel
KV voltage-gated K+ channel
Omega omega pore conductance
NaL background Na+ channels
NaV voltage-gated Na+ channel
p Na+/K+-pump
s substance: sodium, potassium, chloride, ﬁxed anion, water
∞ steady-state
Identiﬁers
a gating variable of the Cl− channel
Am membrane area
c concentration
Cl− chloride ion
cm speciﬁc membrane capacity
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Df ﬁber diameter
δ electrical distance from outside where binding site for K+ and S2+ is localized in Kir
E membrane potential
Eion equilibrium potential (Nernst)
F Faraday constant
Fix intracellular ﬁxed anions (e.g., proteinates, phosphates)
g conductance
H+ protons
η scaling factor relating the size ofT-tubular membrane to sarcolemma
J ﬂux
K+ potassium ion
KmK sensitivity of the Na+/K+-pump for extracellular potassium
KmNa sensitivity of the Na+/K+-pump for intracellular sodium
KK dissociation constant of K+ on Kir channels
KS dissociation constant of S2+ on Kir channels
LH hydraulic conductivity
m, h, S gating variables of the voltage-gated Na+ channel (activation, fast, slow inactivation)
n, hK gating variables of the voltage-gated K+ channel (activation, inactivation)
n amount of substance
Na+ sodium ion
Π osmotic pressure
Q charge
R gas constant
S2+ intracellular ﬁxed cation (cytoplasmic blocker of Kir channels)
T absolute temperature
t time
V i cell volume
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